Find and Pitch Jounalists, Get Your Story Covered

Tags: B Corp ESG certification

	Profile	Recent Articles on Subject
1	Andrew Joseph STAT News Reporter at STAT. Covers health, medicine in Europe. London, England health reportingmedicine	STAT+: Bristol immunotherapy improves responses in lung cancer, setting up Phase 3 study - 5 days ago STAT+: Study on Amgen’s ‘bispecific’ immunotherapy could lead to approval in small cell lung cancer - 11 months ago
2	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	FDA Approves Epcoritamab for Treatment of Relapsed, Refractory Follicular Lymphoma - 3 months ago Study: Mutation Found to Make Follicular Lymphoma More Susceptible to Experimental Drug - 6 months ago FDA Grants Priority Review to Epcoritamab-bysp for Relapsed or Refractory Follicular Lymphoma - 7 months ago
3	Alana Hippensteele, Managing Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	Managing Adverse Event Profiles for Three Bispecific Antibodies Approved for Lymphoma - 6 months ago
4	Ian Ingram MedPage Today Deputy Managing Editor. MedPage Today. New York, New York medical journalismediting	FDA Approves First CAR-T for Chronic Lymphocytic Leukemia - 6 months ago JAK1 Inhibitor Shows 'Remarkable' Activity in T-Cell Lymphoma - 9 months ago Non-Covalent BTK Inhibitor Approved for CLL - 10 months ago
5	Erin Hunter, Associate Editor Pharmacy Times Actor-writer. Nominated BBC Popcorn. London, United Kingdom actingwritingcomedy	CART T-Cell Therapy A2B530 Receives Orphan Drug Designation for the Treatment of Colorectal Cancer - 7 months ago
6	Isabella Cueto STAT News Journalist on chronic disease. healthjournalism	STAT+: Mystery of allergic memory gets closer to answer: a rare group of B cells - 7 months ago
7	<em>The Scientist</em> Staff The Scientist Exploring Life, Inspiring Innovation. scienceinnovation	Building Broader B Cell Diversity for Better Monoclonal Antibody Discovery - 8 months ago Building Broader B Cell Diversity for Better Monoclonal Antibody Discovery - 8 months ago
8	Greg Laub MedPage Today Director of Video at MedPage Today. Screenwriter, previous managing editor. videographyscreenwritingediting	Pirtobrutinib Shows Potential in Heavily Pretreated Follicular Lymphoma - 8 months ago Novel Combination Active in Large B-Cell Lymphoma, Even After CAR-T - 8 months ago Axi-Cel Shows Durable Responses, Prolongs Overall Survival in Older LBCL Patients - 9 months ago Liso-Cel a Potential New CAR-T Option for High-Risk R/R Follicular Lymphoma - 9 months ago Tisa-Cel Yields Durable Responses in R/R Follicular Lymphoma - 9 months ago Responses to Mosunetuzumab in Follicular Lymphoma Remain Durable at 3 Years - 9 months ago Positive Results for Odronextamab in Relapsed/Refractory DLBCL - 9 months ago
9	Erin Hunter, Assistant Editor Pharmacy Times Actor-writer. Nominated BBC Popcorn. London, United Kingdom actingwritingcomedy	Duel-Acting CAR T-Cell Therapy May Address Unmet Need in the Treatment of Patients with B-Cell Malignancies - 9 months ago More than 80% of Patients with Diffuse Large B-cell Lymphoma Responded to Novel Therapeutic, according to the Results of a Preclinical Trial - 9 months ago Hispanic Patients with Philadelphia (Ph)-Like B-cell Acute Lymphoblastic Leukemia Continue to Experience Poor Outcomes, According to Expert - 9 months ago
10	Emily Mullin Wired Staff writer at WIRED. Covers biotechnology. Fall 2021 fellow. Pittsburgh, Pennsylvania biotechnology	In a World First, a Patient's Antibody Cells Were Just Genetically Engineered - 9 months ago

Journalists covering b cell